JFIF"Photoshop 3.08BIM?First patient enrolled in Phase 3 trial of mocertatug rezetecan720260727PSCIENMAGUAuthoreFirst patient enrolled in Phase 3 trial of mocertatug rezetecan for platinum-resistant ovarian cancer Science@https://scienmag.com/first-patient-enrolled-in-phase-3-trial-of-© 2026 Sciencehttps://scienmag.com/Philadelphia, PA, USA — July 27, 2026 — The GOG Foundation, Inc. announced the enrollment of the first patient in GOG-3132/BEHOLD-Ovarian01 (NCT07286266), a global Phase 3 trial evaluating mocertatug rezetecan against standard-of-care chemotherapy in participants with platinum-resistant ovarian cancer. Sponsored by GSK and conducted in collaboration with The GOG Foundation, the study marks a key […]ScienceMedMedicineMedicine1ADC therapy for platinum-resistant ovarian cancer)B7-H4 immune checkpoint in ovarian cancerGOG-3132/BEHOLD-Ovarian01 trialGSK mocertatug rezetecan study#mocertatug rezetecan clinical trial/monoclonal antibody-drug conjugates in oncology-novel treatments for resistant ovarian cancer&ovarian cancer therapeutic developmentPhase 3 ovarian cancer trial!platinum-resistant ovarian cancer3targeted antibody-drug conjugate for ovarian cancerC    !'"#%%%),($+!$%$C   $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$" ?!1AQaq"2#B3b$4Rr%C1!1AQq"2a3BR ?RJ˖dв2Zaj˪Ⱦ㌸|yR!,QahCpR}Il)D#?BkS X]#g2'H{3o.[aAÑԳRk;7W -[`gLGG҈j$؟ui3.O8| tqO_J̮%Ϲ)>%)*\V% ޕ#<> =bۧ`{[l(euWO0 l:g[S!%)f2F ‘|EٶZjq=J9O~5I im-c劽2ˤ<KdѶL6m:fÁ]A$g!H u]9voB JnԂKk|<)*$D5U[a%!s{MA-ݡiٖyѤɊNGmRؕoUvh6[5vTZYnJmjBSƚt,($9R5\2\mCM[wj؃b)Vۡn0S qQ[bn:ֶC6W@nhnGҬbI#hS&%o'oʢ2#*dwRqwO/:7--.n9\cu> `X>5]!e6p}GM^!ke馠JasP?JJŵKk3˟d߸i{s% ( 2"0h-k^whSaUL 5l 䇕̬檰 [Z7.֠}2i* fLJ&2Rs +Z<.O kn)R\!lp``JEjOQ&or|+) y ֖PjJpA>o Oɸ9!q[Zp,;Cq3X)!ndP>GE $i I  !X#$s 1WdĆ[\T)+ߴ\vUĐny=( ¼u55 gXZNīDRR+GR$O5-m*AI?s֏;=U%+;`>՗'{_o0"mm|/]_f]n` qq8̐(q+i_umy>VjiVtoi0K8u^ IZI)&;.Qҧﶠq͹mֲsC[!nhȂ6x6 R1fŸem}<'f#O#.3o ;|))ic}HƆB#YagdCH;xk6 9-NA,91I6Iy!1X C wβvW R"HQߘkM["hG}cq{B]m$gҲ+֦]R:YI<0+ ;ijַҲ $D{9"3B-H=@AceSc[a\Jm|4pj2=Ԑ*->&6wY9}0lޤ, I57epT|sJȕi)OZ3ol(į G fy6M6N~`Ӝ6xtos%6F14$e\eQYA'))JS2kFER2P3ƷNiVD*PaF>%Tug@yXr#8}2n* L\OWh+S8fd0> aIow!NXxq#|>`V56w$% ظCLb /GJN%%?%*J)$93 H0.zv5~%'~X tՒ;l{$gpЕл %J`~y4R%tbTm/:N2G0!2L>#uA52a%?JlliE*#P//It M;!^sÝ `É0dO%P 4>n\FAQT7h6=;=+)P9}hܵ$7)(,c \xinJUguowiˊ:S H!JH.pLĂ#J#30֞$ ta6}?"4?!ą$`B]PxHDP"q6JS|X,^As^)Z،;q.Iim84-$VUmaݜN)CZTLd!pVimC.kX%~tHI`R@ S265+aH?VpԷ'P_)W1˶9MHjzmUZ3$:r+T_Mڞݣ[]X V3ž@[5EdrooHl9 s#Ԏ$8n81i7uRL{%;%!$6H҂3?PĈ gʘwVUi*˂)|'pw#rGCWxxJRZ*V cq9#*%CYR - >*y<+*KCS5aM6:GZBa^e,1hR n:M:Zo@nS%NJz9;άR#aQRCyx%K#l sLeK.eSQwm(a狯vV]x?R崨= mq{KY}>-9kRꊜ=M?0XQV%G'|U3 #u*+R%|ftDe@Q ?:&쏄+ R01}j-i.$Cm\("n}9IU-\$>mqq%?:%ߠ =m6a)u_{7!?}7׽U$.a 2x"trR\;kQ55/4[e)E*1"CԌ{+&S~I9?*MFK0܂ 'Zhw "\+S FB|qUIY*oi|9}~vRr皯'UXK%ޭ=lԭG'Oj$=vgl#!s"sΖ|Lp7\ìGS&72KMRHJmh"#c"(^mR=SWt 斥ZJ>XIm{ʂ$2^e!'epTeG{ZK%вٝ!-,"Ԁ8=)RYU>TeN7Xt 8-]ZB➎ڛ)q<[љdn[)l;[©؏gVtr5d )J%=֟mFYnga 83޴=~Z!$@|ɀhQ9-#&ng77}jOW¶2"ڬ!X+9X&Ofv RlwUI!,6I*ĜiyҾ@Ǐ:fij:pԈ-Xkk}y#q]D%t=l;e]wpaQGJ';0$4׽$x4a*r~|fYJ?-ZEFl:OJH]5&Dha◙-;چrqyT.@#}`mPLd7[T(2@'ʼh99>CN, +<ʹ!2k0_!j$)! *9!_GLAvHgf[de a昌$%"+S D #}30mQ6wT/OҥIӏgV_@QiAAǺ"Bwz:wɮh„jVآV:aPC6`i> Y8fGy `kD=է_{GֻCGրdl-mc ڵQZ,=ig3gH[ϛR' Gs?1]w/F {ijӈqY½|k_ӖLpE68P~G1afJP 5z6z8"ݳhkszlCm$!Fwlc~ ].(΢pJUR}Ha5CMNvQJl9DzE۝J٘mm 3*_ա?)]uj%מRSpԍ>k+̲&0R V@VMlǐҞH PNqdәq ØME$FAgym=\9~s,mGqGmoMi:CC::Jb<UqJdG2 NRkL#%B>v.J¦fQɕ!x}`6PB:g'4*gOYl8R$ NQ+P=Mod:kYIK,7֔AX%œTvOo:tBN 5'C|O@*PWV>g};IOn/pDzR](f͡wcaDTڰ )SW7*_uV5*RjK4 TAׄ\d9V*TݔCTA<<&Edw*TJ?uq`v׋'_RiO̮Zw5oTY4YԩNjk*S/